Interv Akut Kardiol. 2023;22(1):27-34 | DOI: 10.36290/kar.2023.004

Transcatheter treatment of mitral regurgitation

Michael Želízko¹, Vladimír Pořízka¹, Martin Kotrč¹, Theodor Adla², Jiří Malý³

¹ Klinika kardiologie IKEM, Praha

² Základna radiodiagnostiky a intervenční radiologie, IKEM, Praha

³ Klinika kardiochirurgie, IKEM, Praha

Mitral regurgitation is the second most frequent valve disease in the adult population. Until recently, surgical repair or replacement were the only therapeutic options, leaving many patients untreated and even underdiagnosed, most frequently due to a presumably high surgical risk, particularly in those with secondary mitral regurgitation. Over the last few years, there has been exponential growth in the number of catheter-based procedures, with most of them using the transcatheter edge-to-edge repair (TEER) technique. Furthermore, the evolution of other systems is under way that preferentially use the transseptal approach, are more comprehensive, and are aimed at transcatheter mitral valve replacement. The purpose of this article is to review the current transcatheter repair systems and the evidence base for their use.

Keywords: mitral regurgitation, transcatheter, edge-to-edge mitral valve repair.

Accepted: March 27, 2023; Published: April 12, 2023  Show citation